Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Neurology & Psychiatry
Filter     Order     Display # 
Date Item Title
13 May 2008 Cipher provides regulatory update for CIP-Tramadol ER
13 May 2008 Valeant announces succesful completion of Retigabine Phase III epilepsy program validating novel mechanism of action
12 May 2008 Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury
09 May 2008 Orion has decided not to continue the development of a new COMT inhibitor candidate
09 May 2008 U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Add-On Treatment to Lithium or Valproate in the Acute Treatment of Adults With Manic and Mixed Episodes of Bipolar I Disorder With or Without Psychotic Features
08 May 2008 AstraZeneca Submits sNDA for Seroquel XR(TM) for the Treatment of Generalised Anxiety Disorder – a First for the Atypical Antipsychotic Class of Medicines
08 May 2008 FDA Advisory Committee Votes in Favor of Approval of Fospropofol Disodium Injection for Sedation
08 May 2008 FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents
08 May 2008 KeyNeurotek Pharmaceuticals AG Reports Positive Phase I Data of Its Cannabinoid Receptor-Agonist
08 May 2008 New Abbott Study of Investigational Vicodin CR(TM) Meets Primary Efficacy Endpoints in Phase III Trial
08 May 2008 Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents
08 May 2008 Array BioPharma Presents Additional Positive Phase 2 Results in Inflammatory Pain Clinical Trial at the American Pain Society's Annual Scientific Meeting
08 May 2008 Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine
08 May 2008 Abbott Scientists Present A New Approach for Treating Attention-Deficit Hyperactivity Disorder
07 May 2008 NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting
05 May 2008 EPIX Pharmaceuticals Initiates Phase 2b Program in Alzheimer's Disease
05 May 2008 QRxPharma Releases Successful Phase 3 Study Results for ‘Dual Opioid’ Pain Therapy
02 May 2008 Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals' Nicotinic Alpha-7 Agonist, MEM 3454
02 May 2008 Corcept Therapeutics Announces Promising Results of Human Microdosing Study of Selective GR-II Antagonist
01 May 2008 Allon data demonstrate potential of AL-309 as a new neuropathy treatment
01 May 2008 SCOLR Pharma, Inc. Announces Positive Progress for Lead Product
30 Apr 2008 Merck Serono and ZymoGenetics Initiate Atacicept Phase 2 Clinical Trial in Relapsing Multiple Sclerosis
30 Apr 2008 Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
29 Apr 2008 Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
28 Apr 2008 Cara Therapeutics Initiates Phase 1 Clinical Trial of Novel Analgesic, CR845
28 Apr 2008 ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment
25 Apr 2008 Astellas and CoMentis Sign Agreement to Collaborate on the Research, Development and Commercialization of Beta-Secretase Inhibitors
25 Apr 2008 NeuroSearch initiates pivotal Phase III programme with ACR16 for the treatment of Huntington’s disease
25 Apr 2008 Neupro(R) recommended for approval in Europe for Restless Legs Syndrome
24 Apr 2008 King Pharmaceuticals and Acura Pharmaceuticals Announce Completion of Patient Enrollment for Pivotal Phase III Clinical Trial Evaluating ACUROX
23 Apr 2008 MacroChem Acquires Virium Pharmaceuticals
23 Apr 2008 PTC Therapeutics Announces Initiation of Phase 2b Registration-Directed Clinical Trial of PTC124 in Duchenne/Becker Muscular Dystrophy
23 Apr 2008 Amkor Pharma, Inc. Completes All Clinical Activities for Its Phase I Study of Neu2000KL for Treatment of Acute Brain Injury
23 Apr 2008 Biovail Receives FDA Approval for Aplenzin (BVF-033)
23 Apr 2008 Biovail Receives FDA Approval for Aplenzin (BVF-033)
23 Apr 2008 Stem Cell Therapeutics Corp. Receives "May Proceed" From FDA for Its Phase IIb Clinical Stroke Trial and IND
21 Apr 2008 Pipex Pharmaceuticals’ Oral Flupirtine Receives IND with FDA For Phase II Clinical Trial For Fibromyalgia
18 Apr 2008 Medivation's Dimebon(TM) Significantly Improved Thinking and Memory in Alzheimer's Disease Patients Over One Year
17 Apr 2008 BrainCells Inc. Initiates Phase 2 Clinical Trial with BCI-540 for Depression with Anxiety
16 Apr 2008 Patients with early Parkinson's disease show better symptom control and improvements in daily activities with Stalevo than levodopa/carbidopa
16 Apr 2008 Xanthus' Symadex Reverses Disease inPreclinical Mouse Models of Multiple Sclerosis
16 Apr 2008 Data presented at the 60th Annual Meeting of the American Academy of Neurology offers additional support for plasma exchange as a potential tool to accelerate Tysabri (R) removal
16 Apr 2008 Results from Largest Statin Study of Patients with Alzheimer’s Disease Show Lipitor(R) Has No Significant Impact on Disease
16 Apr 2008 Teva Seeks Approval for the Extension of its Indication to Include the Treatment of Patients with a First Clinical Event Suggestive of MS
15 Apr 2008 FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment
15 Apr 2008 Treximet (sumatriptan and naproxen sodium) tablets approved by FDA for acute treatment of migraine
14 Apr 2008 Cephalon Announces European Commission Approval of EFFENTORA for the Treatment of Breakthrough Cancer Pain
14 Apr 2008 Supplemental New Drug Application for RISPERDAL(R) CONSTA(R) Submitted to the FDA for the Treatment of Frequently Relapsing Bipolar Disorder
14 Apr 2008 IMPAX to Develop Next-Generation Carbidopa/Levodopa Product
14 Apr 2008 Pluristem's PLX Cells Show a Statistically Significant Advantage in a Pre-Clinical Study in the Multiple Sclerosis Model
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 251 - 300 of 1619

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics